Necrotic Enteritis in Poultry: Bacterial Causes and Clinical Management

What is Necrotic Enteritis

Necrotic enteritis (NE) is a significant enteric disease of commercial poultry, primarily broiler chickens, caused by the anaerobic, Gram-positive, spore-forming bacterium Clostridium perfringens [1, 2]. The disease manifests in two principal forms: an acute clinical form characterized by sudden onset of depression, diarrhea, and high mortality, and a subclinical (chronic) form that results in poor performance, reduced feed intake, impaired weight gain, and elevated feed conversion ratios without overt mortality [2, 3]. The subclinical form is considered to have the greatest economic impact on the global poultry industry, with annual losses estimated at approximately USD 6 billion [4, 2]. Understanding what is necrotic enteritis requires recognition of its multifactorial nature; the disease typically arises when predisposing factors, most notably coccidiosis caused by Eimeria spp., disrupt the intestinal mucosa and create an anaerobic environment conducive to the proliferation of toxigenic C. perfringens [5, 6].

Etiology

Clostridium perfringens: The Causal Agent

Clostridium perfringens is the etiological agent of necrotic enteritis in poultry [1, 7]. This bacterium is ubiquitous in the environment, found in soil, dust, sewage, and the gastrointestinal tract of healthy birds [8]. C. perfringens is a straight or rod-shaped, Gram-positive anaerobe capable of forming heat-resistant spores that facilitate its persistence in poultry house litter and feed [8, 7]. Pathogenic strains responsible for NE are classified primarily as type A and type G based on their toxin production profiles [9, 10]. Historically, the alpha-toxin (CPA), a phospholipase C enzyme, was considered the primary virulence factor [10, 11]. However, the discovery of NetB, a pore-forming toxin, has redefined the understanding of NE pathogenesis [2, 10]. NetB is now recognized as a critical virulence determinant, and its presence is a defining characteristic of type G strains [9, 10].

Virulence Factors and Pathogenesis

The pathogenesis of NE involves a complex interplay of bacterial virulence factors and host susceptibility. The key virulence factors include:

NetB Toxin: This beta-pore-forming toxin is essential for the development of necrotic lesions in the chicken intestine [2, 10]. NetB inserts into the plasma membrane of host epithelial cells, forming oligomeric pores that disrupt ion gradients, leading to cell swelling and lysis [10]. The presence of the netB gene is strongly correlated with the ability of C. perfringens isolates to cause NE [9, 10].

Alpha-Toxin (CPA): While historically central, CPA is now understood to play a synergistic or supportive role in pathogenesis [10, 12]. CPA is a phospholipase C that hydrolyzes phosphatidylcholine and sphingomyelin, compromising membrane integrity and activating the arachidonic acid cascade, which contributes to inflammation and tissue damage [10, 11].

Pili and Adhesion: Adherence to the damaged intestinal epithelium is a critical early step in colonization. C. perfringens produces a sortase-dependent pilus, a hair-like surface structure encoded by the VR-10B chromosomal locus [13]. This pilus, composed of structural subunits including FimA and FimB, mediates binding to collagen types I, II, and IV, which are exposed following mucosal damage [13]. Null mutants lacking fimA or fimB are severely attenuated in their ability to cause disease in vivo [13].

Other Virulence Factors: Additional factors contributing to pathogenesis include hyaluronidases and sialidases, which degrade extracellular matrix components and facilitate bacterial spread [9]. The Agr-like quorum sensing (QS) system regulates the expression of several virulence genes, including those involved in toxin production and pilus assembly [14]. Disruption of this QS system attenuates the ability of C. perfringens to cause NE [14].

Predisposing Factors

NE is a multifactorial disease that rarely occurs without predisposing conditions [15, 16]. The most significant predisposing factor is coccidiosis, an enteric infection caused by protozoan parasites of the genus Eimeria [5, 6]. Eimeria spp. replicate within intestinal epithelial cells, causing extensive mucosal damage, hemorrhage, and necrosis [5]. This damage provides the necessary anaerobic environment and nutrient release (e.g., amino acids and peptides) that favor the overgrowth of C. perfringens [5, 6]. Other predisposing factors include dietary changes (e.g., high-protein, wheat- or barley-based diets), immunosuppression, mycotoxin contamination of feed, high stocking density, and poor litter management [15, 16].

Epidemiology

Necrotic enteritis is a global problem affecting poultry production systems worldwide [1, 2]. The disease is most commonly observed in broiler chickens between 2 and 5 weeks of age, although it can also affect turkeys and laying hens [17, 18]. The prevalence of NE has increased significantly following the voluntary withdrawal and regulatory ban of antibiotic growth promoters (AGPs) in many regions, including the European Union and Canada [1, 19, 2]. Surveillance data from Canada (2018-2023) indicate that antimicrobials, particularly bacitracin, remain heavily used for NE control, though alternative strategies such as vaccination are emerging [17]. The economic burden of NE is substantial, driven by mortality in acute cases and by reduced performance and increased medication costs in subclinical cases [2, 5].

Clinical Signs

The clinical presentation of NE varies depending on the form of the disease.

Acute Clinical NE: Birds may be found dead without premonitory signs [20]. Affected birds exhibit depression, anorexia, ruffled feathers, diarrhea (often dark or bloody), and a reluctance to move [20, 8]. Mortality rates can reach 10-40% in untreated flocks [8].

Subclinical NE: This form is more insidious and economically damaging [2, 3]. Clinical signs are non-specific and include reduced feed intake, poor weight gain, uneven flock uniformity, and increased feed conversion ratio [2, 3]. There is no overt mortality, but the cumulative impact on production efficiency is significant [2].

Pathology

Gross pathological lesions are primarily confined to the small intestine, particularly the jejunum and ileum [20]. The intestinal wall is typically distended, friable, and filled with a foul-smelling, dark brown fluid [20]. The mucosal surface is covered by a characteristic "Turkish towel" or "carpet-like" pseudomembrane composed of necrotic debris, fibrin, and inflammatory cells [20]. In severe cases, the mucosa may be hemorrhagic and ulcerated [20].

Histopathological examination reveals severe coagulative necrosis of the villi, with sloughing of the epithelium [8, 20]. The lamina propria is infiltrated by heterophils and mononuclear cells [8]. Large numbers of large, Gram-positive, rod-shaped bacteria are often observed adhering to the necrotic mucosal surface [8, 20].

Diagnostics

Accurate diagnosis of NE is essential for implementing effective control measures. Diagnostic approaches include:

Gross Pathology and Histopathology: Post-mortem examination revealing characteristic intestinal lesions is a primary diagnostic tool [20]. Histopathology confirms the presence of coagulative necrosis and Gram-positive rods [8, 20].

Microbiological Culture: Isolation of C. perfringens from intestinal scrapings or liver samples on selective anaerobic media (e.g., tryptose sulfite cycloserine agar) is confirmatory [8, 21]. However, the presence of C. perfringens alone is not diagnostic, as it can be part of the normal gut microbiota [7].

Molecular Detection: Polymerase chain reaction (PCR) assays targeting the netB gene are used to differentiate virulent from non-virulent strains [9, 21, 22]. Genotyping and whole-genome sequencing provide detailed information on toxinotype, antimicrobial resistance genes, and phylogenetic relationships [9, 21].

Toxin Detection: Immunological methods, such as a rapid agglutination kit using protein A conjugated with anti-alpha-toxin IgG, can detect C. perfringens alpha-toxin in fecal samples [23]. This approach offers a rapid, pen-side diagnostic option [23].

Experimental Models: Standardized in vivo challenge models, often involving co-infection with Eimeria spp. followed by oral inoculation with virulent C. perfringens, are essential for evaluating vaccine efficacy and alternative control strategies [19, 6]. Models based on natural uptake of C. perfringens from the barn environment have also been developed to better simulate field conditions [6].

Treatment

Therapeutic intervention for clinical NE typically involves the administration of antimicrobial agents effective against C. perfringens. Historically, bacitracin, penicillin, and macrolides have been used [17]. However, the emergence of antimicrobial resistance (AMR) is a growing concern [9, 8]. Studies have identified resistance genes, including tet genes (tetracycline resistance) and erm(T) (erythromycin resistance), in C. perfringens isolates from poultry [9]. The presence of multidrug-resistant strains complicates treatment and underscores the need for alternative strategies [9, 8]. Antimicrobial susceptibility testing is recommended to guide therapy [8].

Control and Management

The control of NE requires an integrated approach that combines management practices, nutritional interventions, and biological strategies.

Management Practices

Good management is a cornerstone of NE prevention [15, 16]. Key practices include:

• Litter Management: Maintaining dry, clean litter reduces the sporulation and survival of C. perfringens and Eimeria oocysts [15, 16].
• Stocking Density: Avoiding overcrowding minimizes stress and reduces pathogen transmission [15].
• Biosecurity: Strict biosecurity protocols prevent the introduction of pathogenic strains [15].
• Feed Management: Avoiding abrupt feed changes and using pelleted feeds can reduce the risk of NE [16].
• Coccidiosis Control: Effective control of coccidiosis through vaccination or the use of anticoccidial agents (ionophores or chemical coccidiostats) is critical, as it removes the primary predisposing factor [5, 17].

Nutritional Interventions

Several nutritional strategies have been explored as alternatives to AGPs [24, 25].

• Probiotics: Lactobacillus-based probiotics have shown promise in controlling NE by competing with C. perfringens for adhesion sites, producing antimicrobial substances, and modulating the host immune response [1, 3]. Probiotics can reduce intestinal lesions, improve villus integrity, and enhance growth performance in C. perfringens-challenged birds [1, 3].
• Prebiotics and Organic Acids: These compounds can modulate the gut microbiota, creating an environment less favorable for C. perfringens proliferation [2, 3].
• Plant Extracts: Essential oils and tannins from plant sources exhibit antimicrobial activity against C. perfringens and can improve gut health [26, 25]. Herbal tea extracts have also been investigated for their potential to control NE [26].
• Microelements: Feed additives with prolonged-release technology, such as those based on mineral components, can modify the intestinal microenvironment and inhibit enteropathogens [27].

Vaccination

Vaccination is considered the most sustainable long-term strategy for NE control [28, 29]. Current commercial vaccines are based on the CPA and NetB toxins, but they offer only partial protection [29]. Research is focused on developing more effective vaccines incorporating multiple antigens, including pilus proteins (FimA, FimB), adhesins (CnaA), and other conserved surface proteins [29, 13]. Novel vaccine platforms, including bivalent vaccines targeting both NE and avian colibacillosis, are under development [30]. Adjuvants, such as protein A-IgG matrix complexes, are being evaluated to enhance immunogenicity [31]. In ovo and oral delivery routes are being explored for their practicality in large-scale poultry operations [29].

Bacteriophage Therapy

Bacteriophage therapy represents a promising non-antibiotic alternative [4]. Phage cocktails designed using a cross-resistance-guided strategy, combining phages with complementary host ranges and reciprocal resistance profiles, have demonstrated efficacy in reducing C. perfringens colonization, intestinal lesions, and mortality in NE-challenged chickens [4].

Antimicrobial Stewardship

Given the increasing restrictions on AGP use, antimicrobial stewardship is paramount [17]. The use of medically important antimicrobials should be reserved for therapeutic purposes and guided by susceptibility testing [9, 17]. Surveillance programs, such as the Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS), are essential for monitoring AMU and AMR trends [17].

The following diagram summarizes the key components of an integrated NE control program.

flowchart TD
    A[Necrotic Enteritis Control Program], > B[Management]
    A, > C[Nutrition]
    A, > D[Biological Strategies]
    A, > E[Monitoring]

    B, > B1[Litter Management]
    B, > B2[Stocking Density Control]
    B, > B3[Biosecurity]
    B, > B4[Coccidiosis Control]

    C, > C1[Probiotics]
    C, > C2[Prebiotics / Organic Acids]
    C, > C3[Plant Extracts]
    C, > C4[Microelements]

    D, > D1[Vaccination]
    D, > D2[Bacteriophage Therapy]

    E, > E1[Clinical Surveillance]
    E, > E2[Diagnostic Confirmation]
    E, > E3[Antimicrobial Susceptibility Testing]

Conclusion

Necrotic enteritis remains a major challenge to the global poultry industry, driven by the complex pathogenesis of Clostridium perfringens and the multifactorial nature of the disease. The withdrawal of AGPs has intensified the need for effective, sustainable control strategies. A comprehensive approach integrating robust management practices, nutritional interventions, vaccination, and novel therapeutics such as bacteriophages is essential. Continued research into host-pathogen interactions, virulence mechanisms, and vaccine development, coupled with vigilant antimicrobial stewardship, will be critical for mitigating the impact of this economically devastating disease.

References

[1] Razzaq, S., Hina, Q., Muneeb, M., et al. A Narrative Review on The Beneficial Effects of Lactobacillus Probiotics Against Necrotic Enteritis in Poultry. Bio Communications.

[2] Emami, N., Dalloul, R. Centennial Review: Recent developments in host-pathogen interactions during necrotic enteritis in poultry. Poultry Science.

[3] Khalique, A., Zeng, D., Shoaib, M., et al. Probiotics mitigating subclinical necrotic enteritis (SNE) as potential alternatives to antibiotics in poultry. AMB Express.

[4] Ahn, E., Kim, J., Tobin, I., et al. Cross-resistance-guided phage cocktail design for effective mitigation of necrotic enteritis in poultry. Microbiology Research.

[5] Wiedosari, E., Sani, Y. Coccidiosis as A Predisposition Factor for Necrotic Enteritis in Poultry and Their Prevention. Journal.

[6] He, W., Goes, E., Wakaruk, J., et al. A Poultry Subclinical Necrotic Enteritis Disease Model Based on Natural Clostridium perfringens Uptake. Frontiers in Physiology. *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[7] Johansson, A. Clostridium perfringens the causal agent of necrotic enteritis in poultry. Journal.

[8] Shelke, P., Pawade, M., Mhase, P., et al. Antibiotic Sensitivity and Histopathological Study of Clostridium perfringens Associated with Necrotic Enteritis in Poultry. International Journal of Current Microbiology and Applied Sciences.

[9] García-Vela, S., Martínez-Sancho, A., Ben Said, L., et al. Pathogenicity and Antibiotic Resistance Diversity in Clostridium perfringens Isolates from Poultry Affected by Necrotic Enteritis in Canada. Pathogens.

[10] Flores-Díaz, M., Barquero-Calvo, E., Ramírez, M., et al. Role of Clostridium perfringens Toxins in Necrotic Enteritis in Poultry. Journal.

[11] Gatsos, X. Development of live vectored vaccines targeting the alpha-toxin of Clostridium perfringens for the prevention of necrotic enteritis in poultry. Journal.

[12] Elbaz, A., Gatsos, X., Smooker, P. Recombinant Mutated Vaccine against the Alpha-Toxin of Clostridium Perfringens for the Prevention of Necrotic Enteritis in Poultry. Journal.

[13] Lepp, D., Zhou, Y., Ojha, S., et al. Clostridium perfringens Produces an Adhesive Pilus Required for the Pathogenesis of Necrotic Enteritis in Poultry. Journal of Bacteriology.

[14] Yu, Q., Lepp, D., Mehdizadeh Gohari, I., et al. The Agr-Like Quorum Sensing System Is Required for Pathogenesis of Necrotic Enteritis Caused by Clostridium perfringens in Poultry. Infection and Immunity.

[15] Akram, W., Kaleem, M., Hamza, M., et al. Effect of Management in controlling necrotic enteritis in poultry. International Journal of Multidisciplinary Sciences and Arts.

[16] Tsiouris, V. Poultry management: a useful tool for the control of necrotic enteritis in poultry. Avian Pathology.

[17] Agunos, A., Gow, S., Reid-Smith, R. Trends in Necrotic Enteritis and Coccidiosis Control Practices in Canadian Poultry Flocks, 2018-2023. Avian Diseases.

[18] Piva, A. Necrotic enteritis in poultry. Journal.

[19] Dias, G. S., Chagas, K. P. F., Silva, A. C., et al. Experimental induction of subclinical necrotic enteritis in poultry - a review. Revista Agraria Academica.

[20] Malmarugan, S., Sivaseelan, S., Rajeswar, J. Pathology of necrotic enteritis in poultry. Journal.

[21] Shelke, P. Molecular Profiling of Clostridium perfringens Associated with Necrotic Enteritis in Poultry. Journal.

[22] Shelke, P. Toxinotyping of Clostridium perfringens in Poultry from Necrotic Enteritis Cases. Journal of Animal Research.

[23] Kurnia, R., Nugroho, C. M. H., Silaen, O. S. M., et al. Development of Rapid Detection Kit for Necrotic Enteritis Disease in Poultry using Protein A Agglutination. World's Veterinary Journal.

[24] Naeem, M. Combating necrotic enteritis in poultry through nutritional interventions: a review of alternatives to antibiotics. Animal Diseases.

[25] Carrasco, J. D., Redondo, L., Redondo, E., et al. Use of Plant Extracts as an Effective Manner to Control Clostridium perfringens Induced Necrotic Enteritis in Poultry. BioMed Research International.

[26] Potential effects of herbal tea extracts as an alternative to antimicrobials to control the necrotic enteritis in poultry. Asian Journal of Agriculture and Biology.

[27] Stybel, V., Mazur, I. MICROELEMENTS WITH PROLONGED RELEASE TECHNOLOGY AS A STRATEGY FOR CONTROL OF COCCIDIOSIS AND NECROTIC ENTERITIS IN INDUSTRIAL POULTRY FARMING. Scientific and Technical Bulletin of State Scientific Research Control Institute of Veterinary Medical Products and Fodder Additives and Institute of Animal Biology.

[28] Gaucher, M.-L. Unravelling Necrotic Enteritis in Poultry: The Quest for an Effective Vaccine. Scientia.

[29] Waller, S., Galvão, C. C., Rodrigues, R. R., et al. Clostridium perfringens Antigens and Challenges for Development of Vaccines against Necrotic Enteritis in Poultry. Anaerobe.

[30] Indrawati, A., Safika, S., Nugroho, C., et al. Development and Evaluation of a Bivalent Oil-Adjuvanted Vaccine Against Necrotic Enteritis and Avian Colibacillosis in Poultry. Advances in Animal and Veterinary Sciences.

[31] Rahmi, V. A., Indrawati, A., Poetri, O., et al. Evaluation of a Novel Protein A (Staphylococcus aureus)–IgG Matrix Complex as an Adjuvant for a Poultry Necrotic Enteritis Toxoid Vaccine. Advances in Animal and Veterinary Sciences.

[32] Lee, K.-W. Recent development on controlling necrotic enteritis in poultry. Animal Industry and Technology.

[33] Abid, S., Azeem, T., Chaudhary, Z. I., et al. THREAT OF NECROTIC ENTERITIS IN POULTRY AND ITS CONTROL WITHOUT USE OF ANTIBIOTICS: A REVIEW. Journal.

[34] Mahmood, K., Rahman, S., Hussain, I., et al. Non-antibiotic strategies for the control of necrotic enteritis in poultry. Journal.

[35] Shanmugasamy, M. Development of Vaccines Against Necrotic Enteritis in Poultry. Journal.